281 related articles for article (PubMed ID: 19628768)
1. Rescue of impaired fracture healing in COX-2-/- mice via activation of prostaglandin E2 receptor subtype 4.
Xie C; Liang B; Xue M; Lin AS; Loiselle A; Schwarz EM; Guldberg RE; O'Keefe RJ; Zhang X
Am J Pathol; 2009 Aug; 175(2):772-85. PubMed ID: 19628768
[TBL] [Abstract][Full Text] [Related]
2. Reduced COX-2 expression in aged mice is associated with impaired fracture healing.
Naik AA; Xie C; Zuscik MJ; Kingsley P; Schwarz EM; Awad H; Guldberg R; Drissi H; Puzas JE; Boyce B; Zhang X; O'Keefe RJ
J Bone Miner Res; 2009 Feb; 24(2):251-64. PubMed ID: 18847332
[TBL] [Abstract][Full Text] [Related]
3. Osteopenia and impaired fracture healing in aged EP4 receptor knockout mice.
Li M; Healy DR; Li Y; Simmons HA; Crawford DT; Ke HZ; Pan LC; Brown TA; Thompson DD
Bone; 2005 Jul; 37(1):46-54. PubMed ID: 15869929
[TBL] [Abstract][Full Text] [Related]
4. EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair.
Zhang M; Ho HC; Sheu TJ; Breyer MD; Flick LM; Jonason JH; Awad HA; Schwarz EM; O'Keefe RJ
J Bone Miner Res; 2011 Apr; 26(4):792-802. PubMed ID: 20939055
[TBL] [Abstract][Full Text] [Related]
5. Intact prostaglandin signaling through EP2 and EP4 receptors in stromal progenitor cells is required for normal development of the renal cortex in mice.
Fuchs MAA; Schrankl J; Leupold C; Wagner C; Kurtz A; Broeker KA
Am J Physiol Renal Physiol; 2022 Mar; 322(3):F295-F307. PubMed ID: 35037469
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 inhibits UVB-induced apoptosis in mouse skin by activating the prostaglandin E2 receptors, EP2 and EP4.
Chun KS; Akunda JK; Langenbach R
Cancer Res; 2007 Mar; 67(5):2015-21. PubMed ID: 17332329
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence.
Graham S; Gamie Z; Polyzois I; Narvani AA; Tzafetta K; Tsiridis E; Helioti M; Mantalaris A; Tsiridis E
Expert Opin Investig Drugs; 2009 Jun; 18(6):746-66. PubMed ID: 19426119
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
9. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
[TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2/prostaglandin E2 accelerates the healing of gastric ulcers via EP4 receptors.
Hatazawa R; Tanaka A; Tanigami M; Amagase K; Kato S; Ashida Y; Takeuchi K
Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G788-97. PubMed ID: 17673547
[TBL] [Abstract][Full Text] [Related]
12. COX-2 and prostaglandin EP3/EP4 signaling regulate the tumor stromal proangiogenic microenvironment via CXCL12-CXCR4 chemokine systems.
Katoh H; Hosono K; Ito Y; Suzuki T; Ogawa Y; Kubo H; Kamata H; Mishima T; Tamaki H; Sakagami H; Sugimoto Y; Narumiya S; Watanabe M; Majima M
Am J Pathol; 2010 Mar; 176(3):1469-83. PubMed ID: 20110411
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
14. Fibroblasts express RANKL and support osteoclastogenesis in a COX-2-dependent manner after stimulation with titanium particles.
Wei X; Zhang X; Zuscik MJ; Drissi MH; Schwarz EM; O'Keefe RJ
J Bone Miner Res; 2005 Jul; 20(7):1136-48. PubMed ID: 15940366
[TBL] [Abstract][Full Text] [Related]
15. The effect of deletion of cyclooxygenase-2, prostaglandin receptor EP2, or EP4 in bone marrow cells on osteoclasts induced by mouse mammary cancer cell lines.
Ono K; Akatsu T; Kugai N; Pilbeam CC; Raisz LG
Bone; 2003 Nov; 33(5):798-804. PubMed ID: 14623055
[TBL] [Abstract][Full Text] [Related]
16. Teriparatide (human PTH
Yukata K; Xie C; Li TF; Brown ML; Kanchiku T; Zhang X; Awad HA; Schwarz EM; Beck CA; Jonason JH; O'Keefe RJ
Bone; 2018 May; 110():150-159. PubMed ID: 29408411
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 receptors EP2 and EP4 are down-regulated in human mononuclear cells after injury.
Strong VE; Winter J; Yan Z; Smyth GP; Mestre JR; Maddali S; Schaefer PA; Yurt RW; Stapleton PP; Daly JM
Surgery; 2001 Aug; 130(2):249-55. PubMed ID: 11490357
[TBL] [Abstract][Full Text] [Related]
18. Targeting prostaglandin E2 receptors as an alternative strategy to block cyclooxygenase-2-dependent extracellular matrix-induced matrix metalloproteinase-9 expression by macrophages.
Pavlovic S; Du B; Sakamoto K; Khan KM; Natarajan C; Breyer RM; Dannenberg AJ; Falcone DJ
J Biol Chem; 2006 Feb; 281(6):3321-8. PubMed ID: 16338931
[TBL] [Abstract][Full Text] [Related]
19. The role of prostaglandin E receptor subtypes (EP1, EP2, EP3, and EP4) in bone resorption: an analysis using specific agonists for the respective EPs.
Suzawa T; Miyaura C; Inada M; Maruyama T; Sugimoto Y; Ushikubi F; Ichikawa A; Narumiya S; Suda T
Endocrinology; 2000 Apr; 141(4):1554-9. PubMed ID: 10746663
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 promotes wound-induced migration of intestinal subepithelial myofibroblasts via EP2, EP3, and EP4 prostanoid receptor activation.
Iwanaga K; Okada M; Murata T; Hori M; Ozaki H
J Pharmacol Exp Ther; 2012 Mar; 340(3):604-11. PubMed ID: 22138372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
